申请人:Bissantz Caterina
公开号:US20100113424A1
公开(公告)日:2010-05-06
The present invention relates to a compound of formula I
wherein
Ar, R
1
, R
2
, R
3
, n, and o are as defined herein
or to a pharmaceutically active salt, a racemic mixture, an enantiomer, an optical isomer or a tautomeric form thereof. The present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
本发明涉及一种具有以下式I的化合物,其中Ar、R1、R2、R3、n和o如本文所定义,或者涉及其药用活性盐、消旋混合物、对映体、光学异构体或其互变异构体。本化合物是治疗抑郁症、疼痛、精神病、帕金森病、精神分裂症、焦虑症和注意缺陷多动障碍(ADHD)的高潜力NK-3受体拮抗剂。